Richard D Bruggeman
Overview
Explore the profile of Richard D Bruggeman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raman J, Warrick J, Caruso C, Yang Z, Shuman L, Bruggeman R, et al.
Urology
. 2016 May;
94:314.e1-7.
PMID: 27215483
Objective: To determine the prognostic significance of Forkhead Box A1 (FOXA1) expression in patients with upper tract urothelial carcinoma (UTUC) undergoing radical nephroureterectomy (RNU). Materials And Methods: A retrospective analysis...
2.
Evans J, Crist H, Durvesh S, Bruggeman R, Goldenberg D
Cancer Biol Ther
. 2012 Jun;
13(9):776-81.
PMID: 22688732
Anaplastic thyroid carcinoma (ATC) is an extremely aggressive and rapidly fatal neoplasm. The aim of this study was to identify a limited cell cycle associated protein expression pattern unique to...
3.
Clarke L, Helm K, Hennessy J, Bruggeman R, Clarke J
J Am Acad Dermatol
. 2011 Jun;
66(1):98-105.
PMID: 21669473
Background: The reason psoriasis (PSO) favors extensor skin is unknown. We hypothesized that PSO may involve extensor skin preferentially because of differences in the number or type of dermal dendritic...
4.
Clarke L, Frauenhoffer E, Fox E, Neves R, Bruggeman R, Helm K
J Cutan Pathol
. 2010 Feb;
37(7):737-43.
PMID: 20175824
CD10 is now commonly used to differentiate atypical fibroxanthoma (AFX) from melanoma, spindle cell and dedifferentiated variants of squamous cell carcinoma and leiomyosarcoma. However, we have encountered CD10-positive tumors that...
5.
Clarke L, Fountaine T, Hennessy J, Bruggeman R, Clarke J, Mauger D, et al.
J Cutan Pathol
. 2009 Mar;
36(4):433-8.
PMID: 19278428
Background: Cdc7 is a serine-threonine kinase required for initiation of DNA replication that may play a role in the development and progression of melanoma. Materials And Methods: Tissue microarrays containing...
6.
Bayerl M, Bruggeman R, Conroy E, Hengst J, King T, Jimenez M, et al.
Leuk Lymphoma
. 2008 May;
49(5):948-54.
PMID: 18452097
Sphingosine kinase 1 (SphK1) is an oncoprotein capable of directly transforming cells and is associated with resistance to chemotherapy and radiotherapy. SphK1 is increased in various human cancers; whereas, blockade...
7.
Planas-Silva M, Bruggeman R, Grenko R, Smith J
Exp Mol Pathol
. 2006 Oct;
82(1):85-90.
PMID: 17046747
The aim of this study was to identify molecules involved in the proliferation and survival of recurrent estrogen receptor (ER)-positive breast cancer at the site of metastasis. Most studies of...
8.
Planas-Silva M, Bruggeman R, Grenko R, Smith J
Biochem Biophys Res Commun
. 2006 Jan;
341(1):73-81.
PMID: 16412380
The non-receptor tyrosine kinases c-Src and focal adhesion kinase (Fak) mediate signal transduction pathways that regulate cell proliferation, survival, invasion, and metastasis. Here, we investigated whether c-Src and Fak are...
9.
Clarke L, Bayerl M, Bruggeman R, Mauger D, Ioffreda M, Abou-Elella A, et al.
Am J Surg Pathol
. 2005 Mar;
29(4):452-9.
PMID: 15767797
Background: The CD30-positive lymphoproliferative disorders lymphomatoid papulosis (LyP), primary cutaneous anaplastic large cell lymphoma (C-ALCL), and systemic anaplastic large cell lymphoma (S-ALCL) are lesions that overlap clinically, histopathologically, and immunophenotypically....